Dyslexia Treatment Market is Estimated to Witness High Growth Owing to Advancements
Global dyslexia treatment market is estimated to be valued at USD 7.59 Bn in 2024 and is expected to reach USD 11.74 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. Key TakeawaysKey players operating in the dyslexia treatment market are Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Jubilant Pharma Limited, GSK plc, Eli...
0 Comentários 0 Compartilhamentos 393 Visualizações 0 Anterior